Pharmaids Pharmaceuticals Ltd — Important, 12-02-2026: Company Update

Pharmaids Pharmaceuticals has submitted the Auditors' Reports on its consolidated unaudited financial results for the quarter and nine months. These reports accompany the financial results previously submitted to the Stock Exchange after a Board Meeting. The independent auditor performed a review and found nothing causing them to believe the accompanying statement contains any material misstatement. The auditor noted they did not review two subsidiaries with total revenues of 4.60 Cr and 12.78 Cr, net losses of (0.46) Cr and (1.80) Cr, and total comprehensive losses of (0.48) Cr and (1.76) Cr for the respective periods, relying on other auditors' reports without modifying their conclusion.